Compare DTCX & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DTCX | DRIO |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.9M | 70.6M |
| IPO Year | 2021 | 2013 |
| Metric | DTCX | DRIO |
|---|---|---|
| Price | $1.85 | $6.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $13.60 |
| AVG Volume (30 Days) | ★ 184.4K | 14.9K |
| Earning Date | 08-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.00 | ★ 1559.02 |
| EPS | N/A | ★ 1.75 |
| Revenue | $2,446.00 | ★ $7,394,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $38.77 |
| P/E Ratio | ★ N/A | $3.78 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $1.51 | $5.84 |
| 52 Week High | $3.80 | $17.74 |
| Indicator | DTCX | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 38.38 | 43.31 |
| Support Level | $1.78 | $6.49 |
| Resistance Level | $2.26 | $8.10 |
| Average True Range (ATR) | 0.12 | 0.25 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 27.12 | 1.69 |
Datacentrex Inc is a digital infrastructure and capital deployment company that owns and operates Scrypt compute assets and evaluates strategic transactions across asset-backed operating businesses. Its current operating platform is centered on owned and operated Scrypt-based proof-of-work compute deployed through third-party colocation facilities. Datacentrex monetizes this compute through hashrate marketplace mechanisms and manages a treasury of digital assets and cash in a manner intended to preserve capital and support opportunistic, accretive deployment. The company's operations are principally operated remotely at various data centers throughout the United States.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.